Retatrutide
11 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Retatrutide for cardiovascular diseases | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for coronary artery disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for diabetes mellitus | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 10 |
| Retatrutide for insulin resistance | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for kidney failure, chronic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for metabolic diseases | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for obesity | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 12 |
| Retatrutide for osteoarthritis, knee | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for peripheral arterial disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for renal insufficiency, chronic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |